Breaking News Instant updates and real-time market news.

ALR

Alere

$42.74

0.34 (0.80%)

, ABT

Abbott

$40.98

-0.19 (-0.46%)

09:50
10/19/16
10/19
09:50
10/19/16
09:50

Abbott CEO says 'working through' obtaining regulatory approvals for Alere deal

Abbott (ABT) CEO Miles White said he is "restrained" in what he can say regarding the company's deal with Alere (ALR), but said that Abbott is working on pursuing regulatory approvals for a deal with Alere. White said earlier in the call that he still believes that Alere's business is a good fit to expand Abbott's diagnostics business. Alere shares are up 3% in early trading as Abbott has just concluded its earnings call.

ALR

Alere

$42.74

0.34 (0.80%)

ABT

Abbott

$40.98

-0.19 (-0.46%)

  • 19

    Oct

  • 21

    Oct

  • 06

    Nov

ALR Alere
$42.74

0.34 (0.80%)

08/09/16
08/09/16
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 2. Chevron (CVX) upgraded to Overweight from Neutral at Piper Jaffray with analyst Guy Baber saying the company offers "impressive financial resilience and dividend sustainability." 2. Alere (ALR) upgraded to Buy from Neutral at BTIG with analyst Dane Leone saying the 10-K helped to alleviate concerns that material deficiencies exist with the current financial model and is more comfortable with forecasts, and with the $56 price stated within the Abbott (ABT) merger agreement. 3. Buffalo Wild Wings (BWLD) upgraded to Neutral from Underperform at Credit Suisse with analyst Jason West saying the presence of activist investor Marcato could provide a "floor" for the stock and a be a win-win for shareholders. 4. Waste Management (WM) upgraded to Overweight from Sector Weight at KeyBanc with analyst Joe Box saying he believes volumes are undergoing a positive inflection point and that the company's price gains are sustainable. 5. Skyworks (SWKS) upgraded to Outperform from Underperform at CLSA. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
08/24/16
PIPR
08/24/16
NO CHANGE
PIPR
Abbott, Alere likely to agree to reduced takeover price, says Piper Jaffray
Piper Jaffray analyst Alex Olvera believes that Abbott (ABT) is building evidence to bolster its case that Alere (ALR) has undergone a material adverse change since Abbott agreed to acquire it. However, the analyst says he thinks that Delaware, where any litigation between the companies would occur, has never ruled that a material adverse change has occurred in any other case. Consequently, Olvera says there is "a high probability" that the takeover price for Alere will be lowered by 10%-15%. There is a "medium probability" that the cash component of the offer will be reduced and replaced with stock or Contingent Value Rights, according to the analyst. Finally, there is a "low probability" of the merger being terminated, he wrote.
09/19/16
JEFF
09/19/16
NO CHANGE
Target $48
JEFF
Buy
Abbott unit sale does not impact Alere transaction, says Jefferies
Jefferies analyst Jeffrey Holford believes Abbott's (ABT) sale of its Medical Optics business to Johnson & Johnson (JNJ) does not imply an increased probability that the Alere (ALR) deal will close. After speaking to Abbott management, Holford thinks the proceeds from the sale are more likely to be targeted towards the St. Jude Medical (STJ) acquisition. He believes that deal has a higher probability of closing than Alere. Holford has a Buy rating on Abbott with a $48 price target.
09/29/16
ADAM
09/29/16
NO CHANGE
Target $53
ADAM
Buy
Alere risk-reward looks 'quite good' as deal debate nears end, says Canaccord
Canaccord analyst Mark Massaro said he is optimistic that a conclusion of Abbott (ABT) and Alere's (ALR) merger fight is "not far off" and he still believes Abbott will ultimately acquire Alere, though he also thinks the merger may be decided by a judge. Massaro puts a 65% probability on the likelihood the deal closes at the $56 deal price, a 30% chance that Abbott buys Alere at a lower price nearer to $50 per share, and only a 5% chance the deal breaks, making the risk-reward ratio in Alere shares at current levels "quite good," he tells investors. He trimmed his price target on Alere to $53 from $56 an keeps a Buy rating on the stock.
ABT Abbott
$40.98

-0.19 (-0.46%)

09/29/16
COWN
09/29/16
NO CHANGE
COWN
Outperform
Cowen says views on Dexcom, Insulet not changed by competitor launches
Cowen analyst Doug Schenkel noted that Abbott (ABT) announced yesterday it had received FDA approval for the professional version of its FreeStyle Libre glucose monitoring product and filed the consumer version of Libre, while Medtronic (MDT) also announced FDA approval of its 670G Hybrid Closed Loop system. Schenkel said Abbott's consumer Libre filing comes a few months ahead of his expectations but that Medtronic's timing was in-line with expectations. The analyst said the competitor announcements, which had been expected, do not change his views on DexCom (DXCM), Insulet (PODD), or Tandem Diabetes (TNDM) and he keeps Outperform ratings on all three of those stocks.
09/29/16
BARD
09/29/16
NO CHANGE
BARD
Dexcom, Insulet could be weighed down by competitive concerns, says Baird
Baird analyst Jeff Johnson said that while the FDA approvals announced yesterday for Abbott's (ABT) FreeStyle Libre Pro and Medtronic's (MDT) 670G were largely anticipated, he believes that both approvals came sooner than most expected, as did news that Abbott also recently filed for FDA approval of its consumer Libre system. The approvals could "change the narrative" in diabetes and could weigh on others in the sector in the near-term, most notably Dexcom (DXCM) and Insulet (PODD), Johnson tells investors. He keeps Neutral ratings on both and maintains an Overweight rating on Tandem Diabetes (TNDM), citing valuation for the difference.
10/11/16
COWN
10/11/16
NO CHANGE
Target $85
COWN
Outperform
Cowen says St. Jude advisory common for the industry
While Dear Doctor letters are never a positive, St. Jude Medical's (STJ) medical device advisory relating to a low rate of premature battery depletion in the high voltage portfolio is common in the Cardiac Rhythm Management industry, Cowen analyst Joshua Jennings tells investors in a research note. The analyst sees limited risk to St. Jude's franchise and still expects the takeover by Abbott Laboratories' (ABT) to close by the end of the year. Jennings keeps an Outperform rating on St. Jude shares with an $85 price target. The stock is down 1% to $80.19 in pre-market trading.

TODAY'S FREE FLY STORIES

NKE

Nike

$53.24

0.01 (0.02%)

, AMZN

Amazon.com

$939.79

-15.31 (-1.60%)

10:45
09/26/17
09/26
10:45
09/26/17
10:45
Earnings
On The Fly: What to watch in Nike's earnings report »

Nike (NKE) is scheduled…

NKE

Nike

$53.24

0.01 (0.02%)

AMZN

Amazon.com

$939.79

-15.31 (-1.60%)

UA

Under Armour

$15.43

0.04 (0.26%)

UAA

Under Armour

$16.68

-0.06 (-0.36%)

ADDYY

adidas

$113.80

-1.22 (-1.06%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 03

    Oct

  • 04

    Oct

  • 22

    Oct

ADDYY

adidas

$113.80

-1.22 (-1.06%)

10:45
09/26/17
09/26
10:45
09/26/17
10:45
Hot Stocks
Adidas says will 'fully cooperate with authorities' after arrest of employee »

Adidas issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

10:45
09/26/17
09/26
10:45
09/26/17
10:45
General news
FX Action: The dollar »

FX Action: The dollar…

GOOG

Alphabet

$920.97

-7.56 (-0.81%)

, GOOGL

Alphabet Class A

$934.28

-8.98 (-0.95%)

10:43
09/26/17
09/26
10:43
09/26/17
10:43
Periodicals
Google to split off shopping service to comply with EU demands, Bloomberg says »

Google is planning to…

GOOG

Alphabet

$920.97

-7.56 (-0.81%)

GOOGL

Alphabet Class A

$934.28

-8.98 (-0.95%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 22

    Oct

  • 29

    Nov

JPM

JPMorgan

$93.78

-0.34 (-0.36%)

, PNC

PNC Financial

$132.92

-0.6 (-0.45%)

10:40
09/26/17
09/26
10:40
09/26/17
10:40
Hot Stocks
Deutsche moves to the sidelines on JPMorgan, PNC »

Shares of JPMorgan (JPM)…

JPM

JPMorgan

$93.78

-0.34 (-0.36%)

PNC

PNC Financial

$132.92

-0.6 (-0.45%)

GS

Goldman Sachs

$230.47

0.21 (0.09%)

WFC

Wells Fargo

$54.07

0.04 (0.07%)

MS

Morgan Stanley

$47.55

-0.19 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

  • 03

    Oct

  • 12

    Oct

  • 13

    Oct

  • 13

    Oct

  • 17

    Oct

  • 22

    Oct

  • 29

    Nov

  • 15

    Jan

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

RGEN

Repligen

$43.22

-0.54 (-1.23%)

, GE

General Electric

$25.12

0.01 (0.04%)

10:40
09/26/17
09/26
10:40
09/26/17
10:40
Recommendations
Repligen, General Electric analyst commentary  »

Stephens sees GE resin as…

RGEN

Repligen

$43.22

-0.54 (-1.23%)

GE

General Electric

$25.12

0.01 (0.04%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

  • 02

    Oct

  • 30

    Nov

WEN

Wendy's

$14.91

-0.13 (-0.86%)

10:40
09/26/17
09/26
10:40
09/26/17
10:40
Options
Bullish flow in Wendy's as call buyers gobble up new positions »

Bullish flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 22

    Oct

10:40
09/26/17
09/26
10:40
09/26/17
10:40
General news
Fed governor Brainard steered clear of policy »

Fed governor Brainard…

10:35
09/26/17
09/26
10:35
09/26/17
10:35
General news
U.S. consumer confidence slipped to 119.8 »

U.S. consumer confidence…

CATM

Cardtronics

$26.10

-3.17 (-10.83%)

10:34
09/26/17
09/26
10:34
09/26/17
10:34
Downgrade
Cardtronics rating change  »

Cardtronics downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PFE

Pfizer

$35.48

-0.03 (-0.08%)

10:30
09/26/17
09/26
10:30
09/26/17
10:30
Options
Bullish option flow in Pfizer »

Bullish option flow in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 27

    Sep

  • 27

    Sep

  • 18

    Oct

  • 31

    Oct

  • 08

    Nov

10:30
09/26/17
09/26
10:30
09/26/17
10:30
General news
U.S. Richmond Fed's manufacturing index rose to 19 in September »

U.S. Richmond Fed's…

NSRGY

Nestle

$83.75

0.88 (1.06%)

, VZ

Verizon

$49.83

-0.075 (-0.15%)

10:29
09/26/17
09/26
10:29
09/26/17
10:29
Hot Stocks
Nestle sets new profit targets, though stance on L'Oreal stake unchanged »

Shares of Nestle (NSRGY)…

NSRGY

Nestle

$83.75

0.88 (1.06%)

VZ

Verizon

$49.83

-0.075 (-0.15%)

LRLCY

L'Oreal

$43.13

-0.19 (-0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 19

    Oct

RGEN

Repligen

$43.22

-0.54 (-1.23%)

, GE

General Electric

$25.09

-0.025 (-0.10%)

10:28
09/26/17
09/26
10:28
09/26/17
10:28
Recommendations
Repligen, General Electric analyst commentary  »

GE launch to weight on…

RGEN

Repligen

$43.22

-0.54 (-1.23%)

GE

General Electric

$25.09

-0.025 (-0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Sep

  • 02

    Oct

  • 30

    Nov

ADDYY

adidas

$113.80

-1.22 (-1.06%)

, NKE

Nike

$53.21

-0.025 (-0.05%)

10:28
09/26/17
09/26
10:28
09/26/17
10:28
Periodicals
Adidas, Nike employees reportedly named in FBI corruption probe »

The head of sports…

ADDYY

adidas

$113.80

-1.22 (-1.06%)

NKE

Nike

$53.21

-0.025 (-0.05%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

CCL

Carnival

$65.80

2.3 (3.62%)

10:27
09/26/17
09/26
10:27
09/26/17
10:27
Hot Stocks
Carnival says booking volumes for 2018 ahead of prior year »

Says Booking volumes for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

10:25
09/26/17
09/26
10:25
09/26/17
10:25
General news
The 3.4% August U.S. new home sales drop »

The 3.4% August U.S. new…

X

U.S. Steel

$24.36

0.305 (1.27%)

10:21
09/26/17
09/26
10:21
09/26/17
10:21
Periodicals
U.S. Steel spokesperson tells Bloomberg company has not sold Slovak unit »

Bloomberg cites U.S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

X

U.S. Steel

$24.36

0.305 (1.27%)

10:20
09/26/17
09/26
10:20
09/26/17
10:20
Periodicals
Chinese company nearing acquisition of U.S. Steel's Kosice, Spectator reports »

The sale of U. S.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DWDP

DowDuPont

$70.44

0.1 (0.14%)

, LLEX

Lilis Energy

$4.44

0.09 (2.07%)

10:20
09/26/17
09/26
10:20
09/26/17
10:20
Initiation
On The Fly: Top five analyst initiations »

Catch up on today's…click here.

DWDP

DowDuPont

$70.44

0.1 (0.14%)

LLEX

Lilis Energy

$4.44

0.09 (2.07%)

ALDR

Alder Biopharmaceuticals

$11.15

0.3 (2.77%)

CORI

Corium

$10.88

0.03 (0.28%)

TGNA

Tegna

$12.92

0.06 (0.47%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 26

    Sep

  • 27

    Sep

JPM

JPMorgan

$93.84

-0.28 (-0.30%)

, PNC

PNC Financial

$132.62

-0.905 (-0.68%)

10:20
09/26/17
09/26
10:20
09/26/17
10:20
Downgrade
On The Fly: Top five analyst downgrades »

Catch up on today's…click here.

JPM

JPMorgan

$93.84

-0.28 (-0.30%)

PNC

PNC Financial

$132.62

-0.905 (-0.68%)

AFL

Aflac

$83.23

-1.03 (-1.22%)

CATM

Cardtronics

$26.10

-3.17 (-10.83%)

CAKE

Cheesecake Factory

$41.60

0.08 (0.19%)

SHAK

Shake Shack

$31.60

-2.015 (-6.00%)

HABT

Habit Restaurants

GNCA

Genocea

$5.33

0.04 (0.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 28

    Sep

  • 02

    Oct

  • 12

    Oct

  • 13

    Oct

  • 22

    Oct

  • 27

    Feb

  • 13

    Apr

  • 14

    Jul

  • 12

    Oct

DISCA

Discovery

$21.35

-0.06 (-0.28%)

, MO

Altria Group

$64.87

1.08 (1.69%)

10:20
09/26/17
09/26
10:20
09/26/17
10:20
Upgrade
On The Fly: Top five analyst upgrades »

Catch up on today's…click here.

DISCA

Discovery

$21.35

-0.06 (-0.28%)

MO

Altria Group

$64.87

1.08 (1.69%)

LB

L Brands

$42.77

1.87 (4.57%)

SAM

Boston Beer

$159.25

6.25 (4.09%)

BTI

British American Tobacco

$62.01

0.02 (0.03%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Nov

NKE

Nike

$53.28

0.05 (0.09%)

10:20
09/26/17
09/26
10:20
09/26/17
10:20
Options
Nike option volume heavy pre-earnings with shares flat near $53.16 »

Nike option volume heavy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 04

    Oct

10:20
09/26/17
09/26
10:20
09/26/17
10:20
General news
U.S. consumer confidence dipped 0.6 points to 119.8 in September »

U.S. consumer confidence…

CCL

Carnival

$65.92

2.4185 (3.81%)

, AAPL

Apple

$150.55

-1.34 (-0.88%)

10:18
09/26/17
09/26
10:18
09/26/17
10:18
Hot Stocks
Carnival to launch digital streaming channel Ocean View »

Continues to project cash…

CCL

Carnival

$65.92

2.4185 (3.81%)

AAPL

Apple

$150.55

-1.34 (-0.88%)

AMZN

Amazon.com

$939.79

-15.31 (-1.60%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Sep

  • 03

    Oct

  • 22

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.